Fig. 1From: Progression analysis versus traditional methods to quantify slowing of disease progression in Alzheimer’s diseaseEstimated mean trajectory of the ADNI participants’ data (placebo) and the corresponding active treatment arm. The active treatment arm is derived by applying a proportional 20% time delay in disease progression at each visit compared to placebo (dashed horizontal lines)Back to article page